Search Results 961-970 of 18374 for Lactation

  1. Study of Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder - Mayo Clinic

    Lactating females are not eligible unless they have agreed not to breastfeed their infants. Female patients of childbearing potential are not eligible ...

  2. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The purpose of this study is to investigate how abrupt loss of ovarian hormones following bilateral oophorectomy affects overall aging, physical performance ...

  3. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

    Women who are lactating or of reproductive age without a negative pregnancy test and without a commitment to using a highly effective method of ...

  4. Mayo Clinic

    I've been on staff at the Mayo Clinic since 1997 and my whole career has really been focused on treating cancer. I'm Dr. Steven Alberts.

  5. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    The purpose of this study is to investigate how abrupt loss of ovarian hormones following bilateral oophorectomy affects overall aging, physical performance ...

  6. Study of Sc-FOS for Pouchitis Prevention - Clinical Trials

    Lactation; Concurrent treatment for IBD or pouchitis. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

  7. A Study to Evaluate the Effectiveness and Safety of AKCEA-TTR-LRx in Patients with ATTR CM - Mayo Clinic

    - Females must be non-pregnant and non-lactating, and either surgically sterile or post-menopausal or abstinent. If engaged in sexual relations of child ...

  8. I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (I-SPY) - Mayo Clinic

    Non-pregnant and non-lactating; No ferromagnetic prostheses. Patients who have metallic surgical implants that are not compatible with an MRI machine are not ...

  9. PAC203: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL) (PACIFICA) - Mayo Clinic

    Women who are pregnant or lactating. Concurrent enrollment in another interventional trial. Participating Mayo Clinic locations. Study statuses change often ...

  10. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

    Currently pregnant, have intentions to become pregnant during the study duration, or are currently lactating. Has dysphagia, short-gut syndrome ...